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Abstract The pathogenesis of ankylosing spondylitis (AS) is
not well understood, and treatment options have met with
limited success. Autophagy is a highly conserved mechanism
of controlled digestion of damaged organelles within a cell. It
helps in the maintenance of cellular homeostasis. The process
of autophagy requires the formation of an isolationmembrane.
They fo rm doub l e -membraned ves i c l e s ca l l e d
“autophagosomes” that engulf a portion of the cytoplasm.
Beyond the role in maintenance of cellular homeostasis, au-
tophagy has been demonstrated as one of the most remarkable
tools employed by the host cellular defense against bacteria
invasion. Autophagy also affects the immune system and thus
is implicated in several rheumatic disease processes. In this
article, we explore the potential role of autophagy in the path-
ogenesis of AS.
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Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory arthri-
tis affecting young men and women, resulting in significant
disability and impact on quality of life. AS manifests
predominantly with severe back pain due to spinal arthritis
and with peripheral joint involvement in a proportion of pa-
tients [1]. The pathogenesis of AS is not well understood, and
treatment options have met with limited success. Novel path-
ogenic mechanisms are being investigated to better under-
stand the pathogenesis of AS and recently autophagy has been
identified as a potential player. Autophagy is a highly con-
served mechanism, from yeast to mammals, of controlled di-
gestion of damaged organelles within a cell essential for the
maintenance of cellular homeostasis [2]. Under nutrient de-
pletion conditions, cells recycle intracellular energy resources
and under stress conditions cytotoxic proteins and damaged
organelles are removed through autophagy [2].
Types of autophagy
Three different types of autophagy, differing in their mecha-
nisms and functions, have been described [3]: (i)
macroautophagy (in which the entire regions of cytosol are
sequestered in vesicular compartments), (ii) microautophagy
(mediated by direct lysosomal engulfment of cytoplasmic
components), and (iii) chaperone-mediated autophagy (that
is exclusively dedicated to degradation of soluble proteins).
Macroautophagy is the most prevalent autophagy mechanism
and is referred to as Bautophagy^ in this review.
Mechanism of autophagy
The process of autophagy requires the formation of isolation
membranes (phagophores) that elongate engulfing a portion
of the cytoplasm. They form double-membraned vesicles
called Bautophagosomes.^ The formation of autophagosomes
takes place in four major steps: initiation, nucleation,
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elongation, and closure. Each step is strictly regulated by pro-
teins encoded by autophagy-related genes (ATGs) [3].
The initiation of autophagy takes place through the activa-
tion of the unc-51-like kinase 1 (Ulk1) complex. This Ulk
complex is formed by the Ulk1 Ser/Thr protein kinase that
mediates the phosphorylation of Atg13 and FIP200 and is
essential for activating autophagy [4]. This is followed by
phagophore nucleation that requires the Beclin1/hVps34 com-
plex, consisting of Beclin1, hVps34, hVps15, and Atg14 [5].
Subsequently, autophagosome elongation and closure hap-
pens that requires two ubiquitin-like conjugation systems:
Atg12 and light chain 3 (LC3) [6]. The cytosolic isoform of
LC3 (LC3-I) is conjugated to phosphatidylethanolamine
through two consecutive ubiquitination-like reactions. Atg7
and Atg3 are ubiquitin-like modifier-activating enzymes.
The first step of LC3-I modification is catalyzed by the E1-
like enzyme Atg7 followed by the E2-like enzyme Atg3,
forming LC3-II [6]. LC3-II formation is used as a marker for
autophagosomes in studies. Finally, the autophagosomes
merge with lysosomes to form autolysosomes and lysosome
enzymes can degrade the macromolecules engulfed by
autophagosomes [6].
Autophagy in health and disease
Beyond the role in maintenance of cellular homeostasis, au-
tophagy has been demonstrated as one of the most remarkable
tools employed by the host cellular defense against bacteria
invasion [7]. However, several pathogens can manipulate au-
tophagy using molecular mechanisms as a strategy to establish
persistent infection. Modulation of autophagy by specific in-
testinal microorganisms is observed in the gut of Crohn’s dis-
ease (CD) patients [8], in which polymorphisms in autophagy
genes, such as ATG16L1 and IRGM, are associated with the
incidence of intestinal inflammation [9]. In particular, a single-
nucleotide polymorphism (SNP) encoding a missense variant
in the autophagy gene ATG16L1 (rs2241880, Thr300Ala) is
strongly associated with CD [9]. The T300A variant signifi-
cantly increases Atg16L1 sensitization to caspase-3-mediated
processing, leading to accelerated degradation of Atg16L1
and impaired autophagy that predisposes individuals to CD
[10].
Autophagy also affects the immune system and thus is
implicated in several rheumatic disease processes.
Autophagy can affect the thymic T cell selection process, an-
tigen processing, cross presentation, cell survival, and even
cytokine responses of immune cells. Thus, autophagy is of
paramount importance to the immune system and relevant in
the pathogenesis of rheumatic diseases. During thymic educa-
tion, T cell gets exposed to MHC-peptide complexes on thy-
mic epithelial cells. Only T cells that recognize peptides on
self-MHC and are self-tolerant gets approval for further
development. Autophagosomes with cellular components
can gain access to the MHC-II pathway and thus help present
endogenous peptides to the developing T cells helping in de-
veloping self-tolerance [11, 12].
Autophagy in rheumatic diseases
Autophagy has been linked to several rheumatic diseases.
SNPs in or around the autophagy genes ATG5, ATG7 and
IRGM have been found to be associated with SLE in genome
wide association studies (GWAS) [13]. Autophagy is upregu-
lated in peripheral blood T cells and splenic B cells of lupus-
prone mice, and autophagy could contribute to auto-reactive T
and B cell survival in lupus patients [14].
Compared to healthy control skin samples, systemic scle-
rosis patients have higher levels of autophagy in punch biop-
sies. However, these reports seem to be at odds with the ob-
servation that decreased autophagy increases fibrosis. GWAS
studies in systemic sclerosis have identified associations with
ATG5 [15]. Caveolin 1 is a scaffolding intracellular protein
that regulates autophagy [16]. Caveolin 1-deficient mice show
evidence of systemic sclerosis like changes in the skin as well
as develop pulmonary fibrosis [17].
Compared to normal control tissues, in both RA and OA,
autophagy is upregulated [18]. RA synovial fibroblasts are
resistant to apoptosis due to upregulation of autophagy [19,
20] and interestingly autophagy could contribute to metho-
trexate treatment resistance. Autophagy can activate osteo-
clastogenesis [21, 22]. Osteoclasts mediate erosive disease in
RA. Interestingly, autophagosomes in antigen-presenting cells
have peptidyl arginine deiminase activity (PADI) [23]. PADI
converts arginine to citrulline resulting in the generation of
citrullinated peptides. Autophagy is important for the presen-
tation of citrullinated peptides but not other peptides by APCs
[24]. Thus, a cardinal immune response in RA pathogenesis is
mediated by autophagy.
Autophagy could also contribute to the immunopathogenesis
of pSS. Autophagy is in fact upregulated in Tcells from salivary
glands but not from peripheral blood of primary Sjogren’s
Syndrome (pSS) patients, and it is correlated with disease activ-
ity and damage indices [25]. In pSS, autophagy seems to be also
correlated with the local expression of the pro-inflammatory
cytokines IL-21 and IL-23p19 [25]. Endoplasmic reticulum
stress causes autophagy and apoptosis in salivary glands epithe-
lial cells leading to cell surface and apoptotic bleb re-
localization of Ro/SSA and La/SSB autoantigens [26].
Autophagy in ankylosing spondylitis
Despite the strong association between AS and inflam-
matory bowel diseases (IBD) and the high prevalence of
1434 Clin Rheumatol (2016) 35:1433–1436
subclinical gut inflammation in AS patients, no associa-
tion with autophagy genes was found in GWAS studies
in AS [27]. A recent GWAS identified that anthrax toxin
receptor 2 (ANTXR2), a gene potentially affect new
bone formation, was one of the risk loci for AS [28].
In the peripheral blood from AS patients, ANTXR2 is
downregulated along with the upregulation of miR-124.
Intriguingly, the micro RNA miR-124 targets ANTXR2
and overexpression of miR-124 in Jurkat cells notably
inhibits ANTXR2 expression, promoting JNK activation,
and induces autophagy [29]. Another report on AS ge-
netics suggested borderline significant association with
the LRRK2 gene [30]. LRRK2 is closely linked to au-
tophagy with varying reports suggesting LRRK2 acti-
vates or negatively regulates autophagy [31, 32].
However, this association has not been validated in other
studies.
Autophagy seems to be differentially modulated in AS pa-
tients with expression differences between tissues as well as
different modulation of autophagy pathways within the same
tissue. In the inflamed gut, autophagy, but not CMA, is sig-
nificantly upregulated. This is especially true in the context of
specialized epithelial cells located at the bottom of intestinal
crypts, namely, Paneth ells (PC), and among infiltrating
mononuclear cells. Sequestosome 1 (SQSTM1), an
ubiquitin-binding protein that decreases when autophagy is
induced, was not detectable in the gut of AS patients with
chronic gut inflammation. Inhibition of autophagy and CMA
(with 3-MA and anisomycin) was sufficient, in the presence of
LPS, to increase the mRNA levels of IL-23p19 in the LPMCs
isolated from the gut of AS patients, at the same time inducing
IL-23p19 release. Interestingly, CMAwas significantly down-
regulated in AS and negatively correlated with IL-23
levels, suggesting a role specifically for CMA in mod-
ulating IL-23 response [33]. The increase of IL-23p19
with inhibition of autophagy could be related to the
ability of autophagosomes to sequester and target pro-
inflammatory cytokines for degradation [34].
Unlike in the gut, a recent report indicates that there were
no differences in the expression of autophagy-related genes in
the synovial tissues of patients with spondyloarthritis [35]. In
PBMCs isolated from AS patients, there was decreased ex-
pression of ATG16L1, IRGM, and HSP90AA1 compared to
healthy controls, with no significant modulation of
MAP1LC3A, ATG5, and HSPA8 expression. These findings
suggest that autophagy activation in patients with AS is a
tissue-specific phenomenon with an important role reserved
for the gut. In this regard, autophagy has been demonstrated to
play an important role in the innate immune response against
intestinal bacteria, and its expression seems to be potentially
modulated by specific gut microbiota. The presence of
dysbiosis in the gut of AS patients has been recently proven
[36]. Gut dysbiosis might result in active stimulation of the
innate immune system in AS patients, as indirectly suggested
by the activation of PC in producing their antimicrobial prod-
ucts (lysozyme, phospholipase A2, and defensin 5) [37].
Another function of autophagy is connected to its ability to
target improperly folded proteins for degradation in close con-
nection with the endoplasmic reticulum stress response known
as the unfolded protein response (UPR). Misfolding of HLA-
B27, which can be defined as the propensity of HLA-B27
molecules to oligomerize and form complexes in the endo-
plasmic reticulum (ER) with the chaperone BiP (HSPA5/
GRP78), occurs in AS patients. Unlike transgenic rats where
HLA-B27 is overexpressed and UPR activation is prominent,
accumulation of misfolded heavy chains in AS does not acti-
vate the unfolded protein response. In in vitro studies, autoph-
agy suppression induces a significant increase in free heavy
chains expression that was paralleled by a significant increase
in UPR markers. The inability to demonstrate UPR in some in
vivo studies of AS patients could be due to compensation by
excess autophagy. Autophagy and UPR regulate each other
and perturbations of this fine balance can influence the path-
ogenesis of AS.
Conclusions
Autophagy is an active cellular process that can influence the
immune system in multiple ways. Changes in autophagy have
been linked to several diseases. Autophagy could be a critical
missing link in the pathogenesis of AS. Further assessment of
autophagy in studies on AS pathogenesis is warranted.
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